PHAT CIK: 1783183

Phathom Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.19
FY22:
0.16
FY23:
0.40
FY24:
0.36
FY25:
0.23
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.00
FY22:
0.00
FY23:
0.02
FY24:
0.02
FY25:
0.03
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.19
FY22:
0.16
FY23:
0.41
FY24:
0.38
FY25:
0.26

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.02
FY22:
0.03
FY23:
0.04
FY24:
0.09
FY25:
0.13
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.10
FY22:
0.21
FY23:
0.45
FY24:
0.55
FY25:
0.57
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.07
FY22:
−0.07
FY23:
−0.07
FY24:
−0.25
FY25:
−0.44
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.19
FY22:
0.16
FY23:
0.41
FY24:
0.38
FY25:
0.26

All amounts in billions USD Data source:SEC EDGAR